Lujan, J. V., Lengerke-Diaz, P. A., Jacobs, C., Moreno-Cortes, E. F., Ramirez-Segura, C. A., Choi, M. Y., McCarthy, C., Heinen, A., Kipps, T. J. and Castro, J. E. (2020) “Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels”, Haematologica. Pavia, Italy, 105(1), pp. e22-e25. doi: 10.3324/haematol.2018.212597.